187 related articles for article (PubMed ID: 21489949)
1. Inactivated H9N2 avian influenza virus vaccine with gel-primed and mineral oil-boosted regimen could produce improved immune response in broiler breeders.
Lee DH; Kwon JS; Lee HJ; Lee YN; Hur W; Hong YH; Lee JB; Park SY; Choi IS; Song CS
Poult Sci; 2011 May; 90(5):1020-2. PubMed ID: 21489949
[TBL] [Abstract][Full Text] [Related]
2. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
3. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with an attenuated
Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
[TBL] [Abstract][Full Text] [Related]
10. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
Park JK; Lee DH; Cho CH; Yuk SS; To EO; Kwon JH; Noh JY; Kim BY; Choi SW; Shim BS; Song MK; Lee JB; Park SY; Choi IS; Song CS
Vet Microbiol; 2014 Mar; 169(3-4):211-7. PubMed ID: 24472228
[TBL] [Abstract][Full Text] [Related]
12. Trend of Changes in the Titer of Antibody against Avian Influenza Virus H9n2 during Raising Period in Vaccinated and Unvaccinated Broiler Farms in Qazvin Province, Iran: A Cohort Study.
Mirzaiee K; Shoushtari A; Bokaie S; Fallah Mehrabadi MH; Peighambari SM
Arch Razi Inst; 2020 Mar; 75(1):9-16. PubMed ID: 32291997
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
15. Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.
Gomaa MR; Khalil AA; Kandeil A; Sabir JSM; Kayed A; Moatasim Y; El Saied MF; El-Safty MM; Kayali G; Ali MA
Poult Sci; 2019 Dec; 98(12):6289-6295. PubMed ID: 31265106
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens.
Shin JH; Mo JS; Kim JN; Mo IP; Ha BD
J Vet Sci; 2016 Mar; 17(1):27-34. PubMed ID: 27051337
[TBL] [Abstract][Full Text] [Related]
17. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
18. An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea.
Choi JG; Lee YJ; Kim YJ; Lee EK; Jeong OM; Sung HW; Kim JH; Kwon JH
J Vet Sci; 2008 Mar; 9(1):67-74. PubMed ID: 18296890
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
[TBL] [Abstract][Full Text] [Related]
20. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
Song H; Nieto GR; Perez DR
J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
